KALA - Kala Pharmaceuticals Inc
Kala Pharmaceuticals Inc Logo

KALA - Kala Pharmaceuticals Inc

https://www.kalarx.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of therapies using its proprietary nanoparticle-based mucus penetrating particle (MPP) technology for the treatment of eye diseases. The company is headquartered in Watertown, Massachusetts.

52W High
$15.80
52W Low
$2.92
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
-1.82
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.16
EV/Revenue (<3 favorable)
0.04
P/S (TTM) (<3 favorable)
1.16
P/B (<3 favorable)
8.34
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
1.75%
Institutions (25–75% balanced)
51.86%
Shares Outstanding
7,021,000
Float
4,253,900
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
1,332,000
EPS (TTM)
-5.96
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-7.08%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-1.00
Momentum
Bearish momentum
Value
2.9510
Previous
2.6411
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025